- Home
- MGRX vs INBS Comparison
MGRX vs INBS Comparison
Compare MGRX & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- INBS
- Stock Information
- Founded
- MGRX 2021
- INBS 2016
- Country
- MGRX United States
- INBS United States
- Employees
- MGRX N/A
- INBS N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- INBS Medical Specialities
- Sector
- MGRX Technology
- INBS Health Care
- Exchange
- MGRX Nasdaq
- INBS Nasdaq
- Market Cap
- MGRX 8.1M
- INBS 8.6M
- IPO Year
- MGRX 2023
- INBS N/A
- Fundamental
- Price
- MGRX $2.10
- INBS $1.30
- Analyst Decision
- MGRX
- INBS
- Analyst Count
- MGRX 0
- INBS 0
- Target Price
- MGRX N/A
- INBS N/A
- AVG Volume (30 Days)
- MGRX 223.6K
- INBS 86.4K
- Earning Date
- MGRX 05-14-2025
- INBS 05-07-2025
- Dividend Yield
- MGRX N/A
- INBS N/A
- EPS Growth
- MGRX N/A
- INBS N/A
- EPS
- MGRX N/A
- INBS N/A
- Revenue
- MGRX $615,873.00
- INBS $3,031,405.00
- Revenue This Year
- MGRX N/A
- INBS $280.88
- Revenue Next Year
- MGRX N/A
- INBS $126.26
- P/E Ratio
- MGRX N/A
- INBS N/A
- Revenue Growth
- MGRX N/A
- INBS 23.21
- 52 Week Low
- MGRX $1.49
- INBS $1.00
- 52 Week High
- MGRX $16.80
- INBS $3.04
- Technical
- Relative Strength Index (RSI)
- MGRX 43.32
- INBS 39.13
- Support Level
- MGRX $1.63
- INBS $1.34
- Resistance Level
- MGRX $2.85
- INBS $1.35
- Average True Range (ATR)
- MGRX 0.37
- INBS 0.12
- MACD
- MGRX 0.11
- INBS 0.02
- Stochastic Oscillator
- MGRX 44.24
- INBS 57.14
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).